Healthcare -
Biotechnology - NYSE - US
$ 4.9993
2.24 %
$ 69 M
Market Cap
-1.18
P/E
ANVS - STOCK-BASED COMPENSATION
Stock-based Compensation ANVS - Annovis Bio, Inc.
4.63 M
LAST VALUE
-0.74%
2 YEAR CAGR
123.64%
5 YEAR CAGR
0.00%
10 YEAR CAGR